Iodates And Periodates Market
Iodates And Periodates Market
The market for Iodates And Periodates was estimated at $564.10 million in 2024; it is anticipated to increase to $764 million by 2030, with projections indicating growth to around $985 million by 2035.
Global Iodates And Periodates Market Outlook
Revenue, 2024 (US$M)
Forecast, 2034 (US$M)
CAGR, 2024 - 2034
Market Key Insights
- The Iodates And Periodates market is projected to grow from $564.1 million in 2024 to $936 million in 2034. This represents a CAGR of 5.2%, reflecting rising demand across Chemical Analysis & Experimentation, Water Purification & Food Processing and Medical & Pharmaceutical Industry.
- Sigma-Aldrich Corporation, Combi-Blocks Inc., Loba Chemie are among the leading players in this market, shaping its competitive landscape.
- U.S. and China are the top markets within the Iodates And Periodates market and are expected to observe the growth CAGR of 3.4% to 5.0% between 2024 and 2030.
- Emerging markets including Vietnam, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 6.0% to 7.2%.
- Transition like Harnessing the Potential of Iodates is expected to add $51.1 million to the Iodates And Periodates market growth by 2030
- The Iodates And Periodates market is set to add $372 million between 2024 and 2034, with manufacturer targeting Medical & Food Processing Application projected to gain a larger market share.
- With Growing pharmaceuticals industry, and Emergence of high-performance materials, Iodates And Periodates market to expand 66% between 2024 and 2034.
Opportunities in the Iodates And Periodates
Emerging countries in Asia, Africa, and South America offer fertile grounds for the expansion of the iodates and periodates market. Increased industrial activities in these regions indicate a rising demand for these compounds. Market players can prioritize these growing economies in their market entry tactics.
Growth Opportunities in North America and Europe
North America Outlook
Europe Outlook
Market Dynamics and Supply Chain
Driver: Growing Pharmaceuticals Industry
Restraint: Regulatory Constraints
Opportunity: Expanding Scope in Medical Fields and Technological Innovations in Chemical Synthesis
Challenge: Market Unpredictability
Supply Chain Landscape
BASF SE
Dow Chemical Company
Arkema Group
Solvay S.A
Lanxess AG
AkzoNobel N.V
Water Treatment
Pharmaceuticals
Food
BASF SE
Dow Chemical Company
Arkema Group
Solvay S.A
Lanxess AG
AkzoNobel N.V
Water Treatment
Pharmaceuticals
Food